GlassScriptPhysician profile
Amy C Kim
NPI 1427823632
$3,032.28
in general payments reported to CMS, 2019-2025
25 companies · $1,931 in 2025
The $1,931 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $23.48 · 2024: $1,078 · 2025: $1,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,947 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,947.29 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $405.90 | 2024-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $398.56 | 2025 | Carvykti, Rybrevant, Erleada |
| Sumitomo Pharma America, INC. | $339.57 | 2024-2025 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $262.14 | 2024-2025 | Adstiladrin |
| Avita Medical Americas, LLC | $174.96 | 2025 | Permeaderm, Recell, Cohealyx |
| Merck Sharp & Dohme LLC | $168.41 | 2024 | Keytruda, Welireg |
| Photocure INC | $155.12 | 2024-2025 | Cysview |
| Myriad Genetic Laboratories, INC. | $132.38 | 2024-2025 | Myrisk, Prolaris |
| Olympus America INC. | $117.88 | 2024-2025 | Itind System |
| Urogen Pharma, INC. | $113.24 | 2023-2025 | Jelmyto |
| Medtronic, INC. | $110.39 | 2024 | Interstim |
| Coloplast Corp | $103.66 | 2024-2025 | |
| 180 Medical, INC. | $93.09 | 2024 | Cure Catheter |
| Verity Pharmaceuticals INC. | $76.38 | 2025 | Tlando |
| Antares Pharma, INC. | $73.11 | 2024-2025 | Xyosted |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $67.03 | 2024 | |
| Endo USA, INC. | $41.11 | 2025 | Xiaflex |
| Pfizer INC. | $39.89 | 2025 | |
| Avyxa Pharma, LLC | $29.71 | 2025 | |
| Astellas Pharma US INC | $28.20 | 2025 | Xtandi |
| Convatec INC. | $27.01 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $25.86 | 2025 | Personal Catheter Intermittent Catheter |
| Boston Scientific Corporation | $17.95 | 2025 | Axonics |
| Ambu INC. | $16.61 | 2024 | |
| Angiodynamics, INC. | $14.12 | 2024 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.